Choose your font:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 English 
 Français 
 Português 

[Valid RSS] RSS

Database - Alliance francophone pour l'accouchement respecté (AFAR)

Description of this database

http://afar.info/id=1893

Created on : 28 Mar 2006
Modified on : 02 Dec 2007


 Modify this record
Do not follow this link unless you know an editor’s password!

hard

Author(s) :

Bush MC, Csaba A, Eddleman KA, Saphier CJ.

Bibliographical entry (without author) :

Is misoprostol safe for labor induction in twin gestations?
J Matern Fetal Neonatal Med. 2006 Jan;19(1):35-8.

Year of publication :

2006

Résumé (français) :

Abstract (English):

Objective. To compare the safety and efficacy of intravaginal misoprostol to oxytocin for the induction of labor in twin gestations.Methods. All twin gestations that underwent induction of labor with misoprostol or oxytocin during a 4-year period were identified from the Mount Sinai obstetrical database. Only twins =34 weeks with a vertex presenting twin A were included. Labor and delivery characteristics, maternal complications and neonatal outcomes were compared between the two groups.Results. Of 134 patients with twins, 57 initially received misoprostol and 77 received oxytocin. These groups had similar demographics, but women who received misoprostol had less cervical dilation (0.8 vs. 2.2 cm, p < 0.0001) and were less likely to be multiparous (19% vs. 44%, p = 0.003). There was a shorter length of induction to delivery (7.8 hours vs. 15.1 hours, p = 0.001) and a trend toward a lower cesarean section rate (16.9% vs. 31.6%, p = 0.06) in the oxytocin-only group. There were no cases of uterine rupture or maternal mortality in this series. There were no significant differences in neonatal outcomes between the two groups, but the sample size was underpowered to detect significant differences between the groups.Conclusions. Misoprostol and oxytocin both appear to be safe and efficacious for use in inductions of labor in twins in this limited retrospective investigation. The safety of these agents with regard to neonatal outcomes should be confirmed by larger studies.

Sumário (português):

URL :

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=…

Comments :

Argument (français) :


Argument (English):

Argumento (português):

Keywords :

c-section/caesarean ; induction of labor ; misoprostol (Cytotec) ; evidence-based medicine/midwifery ; oxytocin ; maternal age ; post-term pregnancy

Author of this record :

Cécile_Loup — 28 Mar 2006


DateDiscussion (only in English)Author
 
➡ Only identified users



 I have read the guidelines of discussions and I accept all terms (read guidelines)

barre

New expert query --- New simple query

Creating new record --- Importing records

User management --- Dump database

bar

This database is managed by Alliance francophone pour l'accouchement respecté (AFAR, http://afar.info)
affiliated with Collectif interassociatif autour de la naissance (CIANE, http://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) becoming a member of AFAR
(2) financially supporting AFAR
(3) contributing to this database if you have a minimum training in scientific documentation.
Sign in or create an account to follow changes or become an editor.
Contact afar.association(arobase)gmail.com for more information.

Valid CSS! Valid HTML!